Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 501–600 of 1,002
Flagellin Induces Antibody Responses through a TLR5- and Inflammasome-Independent Pathway
López-Yglesias, A. H., Zhao, X., Quarles, E. K., Lai, M. A., VandenBos, T., Strong, R. K., & Smith, K. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301893 · Cited by 70
“some (49, 50), but alum also uses an inflammasome-independent”
BackgroundAllergic Responses Induced by the Immunomodulatory Effects of Nanomaterials upon Skin Exposure
Yoshioka, Y., Kuroda, E., Hirai, T., Tsutsumi, Y. M., & Ishii, K. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00169 · Cited by 73
“Some reports have shown that aluminum salts induce antigen-specific IgG1 responses that are dependent on the NLRP3 inflammasome (101, 102), although other reports suggest that the NLRP3 inflammasome is not required for the adjuvanticity of aluminum salts (103, 104).”
BackgroundMethodSun, B., Ji, Z., Liao, Y., Chang, C. H., Wang, X., Ku, J., Xue, C., Mirshafiee, V., & Xia, T. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05817 · Cited by 71
Pitenis, A. A., Urueña, J. M., Hart, S. M., O’Bryan, C. S., Marshall, S. L., Levings, P. P., Angelini, T. E., & Sawyer, W. G. (2018) · Tribology Letters · doi:10.1007/s11249-018-1029-7 · Cited by 77
“The primary function of IL-1-type cytokines is to control pro-inflammatory reactions in response to tissue injury by pathogen-associated molecular patterns (PAMPs, such as bacterial or viral products) or, during sterile inflammation, damage- or danger-associated molecular patterns (DAMPs) released from damaged cells,…”
BackgroundAdjuvants for Pandemic Influenza Vaccines
Atmar, R. L., & Keitel, W. A. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-92165-3_16 · Cited by 69
Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination
Zhang, L., Ko, C., Li, Y., Jie, Z., Zhu, L., Zhou, X., Xie, X., Gao, T., Liu, T., Cheng, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109904 · Cited by 70
“…of peritonitis induced by the NLRP3 inflammasome inducer alum, a widely used adjuvant that not only enhances antigen uptake by dendritic cells but also promotes leukocyte recruitment via induction of NLRP3-inflammasomedependent IL-1 β secretion (Eisenbarth et al., 2008; Sokolovska et al., 2007).”
Evaluation of Nod-Like Receptor (NLR) Effector Domain Interactions
Wagner, R. N., Proell, M., Kufer, T. A., & Schwarzenbacher, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004931 · Cited by 70
“Individual NLRs specifically recognize microbial derived non-self products such as peptidoglycan-derived molecules [8,9], viral dsRNA, bacterial toxins, as well as host-derived danger-molecules like uric acid crystals [10–12].”
BackgroundNovel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 80
“Recent knowledge into adjuvanticity indicates that it is possible to use adjuvants to shape the kind of adaptive immune response elicited by a vaccine, by inducing different cytokine profiles (Eisenbarth et al., 2008; Mata-Haro et al., 2007; McCluskie & Krieg, 2006).”
BackgroundChea, E. K., Fernández‐Tejada, A., Damani, P., Adams, M. M., Gardner, J. R., Livingston, P. O., Ragupathi, G., & Gin, D. Y. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305121q · Cited by 73
Adam, C., Wohlfarth, J., Haußmann, M., Sennefelder, H., Rodin, A., Maler, M. D., Martin, S. F., Goebeler, M., & Schmidt, M. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.10.003 · Cited by 75
“…interfering with phagocytosis and inflammasome activation by particulate signal II activators such as silica or alum that trigger lysosomal damage (Eisenbarth et al., 2008, Hornung et al., 2008), successfully blocked alum-induced IL1-β secretion but failed to affect Cr2O7 2-- or ATP-induced IL-1β…”
BackgroundAli, M. F., Dasari, H., Keulen, V. P. V., & Carmona, E. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01504 · Cited by 74
Radzikowska, U., Eljaszewicz, A., Tan, G., Stocker, N., Heider, A., Westermann, P., Steiner, S., Dreher, A., Wawrzyniak, P., Rückert, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37470-4 · Cited by 75
NLRP3 inflammasome in health and disease (Review)
Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., & Liu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5489 · Cited by 76
Immunotherapy applications of carbon nanotubes: from design to safe applications
Fadel, T. R., & Fahmy, T. M. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.02.005 · Cited by 73
Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout
Dalbeth, N., & Merriman, T. R. (2008) · Rheumatology · doi:10.1093/rheumatology/ken460 · Cited by 75
Bolívar, B. E., Vogel, T. P., & Bouchier‐Hayes, L. (2019) · FEBS Journal · doi:10.1111/febs.14926 · Cited by 70
Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants
Miyaji, E. N., Carvalho, E., Oliveira, M. L. S., Raw, I., & Ho, P. L. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500064 · Cited by 66
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialResolving adjuvant mode of action to enhance vaccine efficacy
Turley, J. L., & Lavelle, E. C. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102229 · Cited by 71
Mode of action of adjuvants: Implications for vaccine safety and design
Mastelic, B., Ahmed, S., Egan, W. M., Giudice, G. D., Golding, H., Gust, I. D., Neels, P., Reed, S. G., Sheets, R., Siegrist, C., et al. (2010) · Biologicals · doi:10.1016/j.biologicals.2010.06.002 · Cited by 68
“The immunostimulatory property of aluminium salts has recently been shown to be DC-dependent [4], whereas the T-cell response partially depends on Nalp3 inflammasome activation [5].”
BackgroundShaw, C., Li, Y., & Tomljenovic, L. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.07.022 · Cited by 73
Strain-Dependent Genomic Factors Affect Allergen-Induced Airway Hyperresponsiveness in Mice
Kelada, S. N. P., Wilson, M. S., Tavarez, U. L., Kubalanza, K., Borate, B. R., Whitehead, G. S., Maruoka, S., Roy, M. G., Olive, M., Carpenter, D. E., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0315oc · Cited by 70
Correction: Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases
Shio, M. T., Eisenbarth, S. C., Savaria, M., Vinet, A. F., Bellemare, M.-J., Harder, K. W., Sutterwala, F. S., Bohle, D. S., Descoteaux, A., Flavell, R. A., et al. (2009) · PLoS Pathogens · doi:10.1371/annotation/abca067d-b82b-4de6-93c5-0fcc38e3df05 · Cited by 66
Self-citationSong, Z., Li, B., Zhang, Y., Li, R., Ruan, H., Wu, J. P., & Liu, Q. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01340 · Cited by 72
Barlan, A. U., Danthi, P., & Wiethoff, C. M. (2011) · Virology · doi:10.1016/j.virol.2011.01.019 · Cited by 65
“, 2009) as well as the effectiveness of vaccine adjuvants in some circumstances (Eisenbarth et al., 2008; Li et al., 2008).”
Enoksson, S. L., Grasset, E. K., Hägglöf, T., Mattsson, N., Kaiser, Y., Gabrielsson, S., McGaha, T. L., Scheynius, A., & Karlsson, M. C. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107830108 · Cited by 65
“the NALP3 inflammasome, and this process is crucial for its immunostimulatory properties (39, 40).”
BackgroundNeuroinflammation and Copper in Alzheimer’s Disease
Choo, X. Y., Alukaidey, L., White, A. R., & Grubman, A. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/145345 · Cited by 78
“” Inflammasome assembly may be triggered by diverse stimuli, including uric acid crystals, cholesterol, protein aggregates and, aluminium adjuvants [20–23].”
BackgroundTumor suppressor death-associated protein kinase is required for full IL-1β production
Chuang, Y.-T., Lin, Y.-C., Lin, K.-H., Chou, T.-F., Kuo, W.-C., Yang, K.-T., Wu, P.-R., Chen, R.-H., Kimchi, A., & Lai, M.-Z. (2011) · Blood · doi:10.1182/blood-2010-08-303115 · Cited by 65
Adverse events following immunization with vaccines containing adjuvants
Cerpa‐Cruz, S., Paredes-Casillas, P., Navarro, E. L., Bernard‐Medina, A. G., Martinez-Bonilla, G., & Gutiérrez-Ureña, S. R. (2013) · Immunologic Research · doi:10.1007/s12026-013-8400-4 · Cited by 74
Ruwona, T. B., Xu, H., Li, X., Taylor, A. N., Shi, Y.-C., & Cui, Z. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.081 · Cited by 67
Nakayama, T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.08.051 · Cited by 64
The role of keratinocytes in inflammation
Juráňová, J., Franková, J., & Ulrichová, J. (2017) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2017.05.003 · Cited by 74
Impact of Morphology on Iron Oxide Nanoparticles-Induced Inflammasome Activation in Macrophages
Liu, L., Sha, R., Yang, L., Zhao, X., Zhu, Y., Gao, J., Zhang, Y., & Wen, L. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17474 · Cited by 68
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Bhattacharya, D. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.004 · Cited by 68
“…receptor family pyrin domain containing 3 (NLRP3) inflammasome was considered to be an essential Immunity 55, June 14, 2022 949 sensor for antibody responses downstream of alum, but the results on this point have not been consistent across studies (Eisenbarth et al., 2008; McKee et al., 2009).”
Inflammasomes in infection and inflammation
McIntire, C. R., Yeretssian, G., & Saleh, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0312-3 · Cited by 69
“More recently, aluminum salts, and the amyloid-b peptide were also shown to induce the activation of the NALP3 inflammasome [114, 115].”
BackgroundAn Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines
Salvador, A., Igartúa, M., Hernández, R. M., & Pedraz, J. L. (2011) · Journal of Drug Delivery · doi:10.1155/2011/181646 · Cited by 70
From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology
Boraschi, D., & Italiani, P. (2015) · Vaccines · doi:10.3390/vaccines3040930 · Cited by 77
“In the activity of particulated adjuvants, it is of particular interest that many of them apparently work by contributing to the activation of an intracytoplasmic protein complex, the inflammasome, which has the role of detecting stress signals and activating an enzyme involved in the triggering of inflammatory cytoki…”
BackgroundCui, W., Joshi, N. S., Liu, Y., Meng, H., Kleinstein, S. H., & Kaech, S. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302569 · Cited by 74
Effect of lead exposure on lymphocyte subsets and activation markers
Mishra, K. P., Rani, R., Yadav, V. S., & Naik, S. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903503668 · Cited by 63
Airborne Asian sand dust enhances murine lung eosinophilia
He, M., Ichinose, T., Yoshida, S., Nishikawa, M., Mori, I., Yanagisawa, R., Takano, H., Inoue, K., Sun, G., & Shibamoto, T. (2010) · Inhalation Toxicology · doi:10.3109/08958378.2010.510151 · Cited by 62
“However, silica activates NALP3 inflammasome in the LPS-stimulated macrophages, as does aluminium adjuvants (Eisenbarth et al., 2008), and this leads to subsequent IL-1β secretion (Cassel et al., 2008).”
BackgroundInfluentialOleszycka, E., Moran, H. B. T., Tynan, G. A., Hearnden, C. H. A., Coutts, G., Campbell, M., Allan, S. M., Scott, C. J., & Lavelle, E. C. (2015) · FEBS Journal · doi:10.1111/febs.13546 · Cited by 70
Novel antigens in type 1 diabetes: The importance of ZnT8
Wenzlau, J. M., Frisch, L. M., Gardner, T. J., Sarkar, S. A., Hutton, J. C., & Davidson, H. W. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0019-4 · Cited by 70
Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome?
Meroni, P. L. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.10.004 · Cited by 63
Yang, Y., Zhou, X., Kouadir, M., Shi, F., Ding, T., Liu, C., Liu, J., Wang, M., Yang, L., Yin, X., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit347 · Cited by 61
“the activation of the NALP3 inflammasome [29, 30] and the AIM2 inflammasome [22].”
BackgroundLicensing Adaptive Immunity by NOD-Like Receptors
Liu, D., Rhebergen, A. M., & Eisenbarth, S. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00486 · Cited by 72
Self-citationWigren, M., Bengtsson, D., Dunér, P., Olofsson, K., Björkbacka, H., Bengtsson, E., Fredrikson, G. N., & Nilsson, J. Å. (2009) · Circulation Research · doi:10.1161/circresaha.109.196667 · Cited by 61
Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome
Liu‐Bryan, R. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.93 · Cited by 65
A Role of IgM Antibodies in Monosodium Urate Crystal Formation and Associated Adjuvanticity
Kanevets, U., Sharma, K., Dresser, K., & Shi, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803777 · Cited by 74
Emmadi, M., Khan, N., Lykke, L., Reppe, K., Parameswarappa, S. G., Lisboa, M. P., Wienhold, S.-M., Witzenrath, M., Pereira, C. L., & Seeberger, P. H. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07836 · Cited by 60
Transcription factors in parathyroid development: lessons from hypoparathyroid disorders
Grigorieva, I. V., & Thakker, R. V. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06221.x · Cited by 62
Cellular networks controlling Th2 polarization in allergy and immunity
Kool, M., Hammad, H., & Lambrecht, B. N. (2012) · F1000 Biology Reports · doi:10.3410/b4-6 · Cited by 79
“Li H, Willingham SB, Ting JP, Re F: Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3.”
BackgroundInfluentialA micro-sterile inflammation array as an adjuvant for influenza vaccines
Wang, J., Shah, D., Chen, X., Anderson, R., & Wu, M. X. (2014) · Nature Communications · doi:10.1038/ncomms5447 · Cited by 60
de Veer, M., Kemp, J. M., Chatelier, J., Elhay, M. J., & Meeusen, E. N. T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.056 · Cited by 60
Clinical use of adjuvants in allergen-immunotherapy
Klimek, L., Schmidt‐Weber, C. B., Kramer, M. F., Skinner, M. A., & Heath, M. D. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1292133 · Cited by 65
Li, W., Zeng, H., Xu, M., Huang, C., Tao, L., Li, J., Zhang, T., Chen, H., Xia, J., Li, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.697483 · Cited by 67
“Due to ROS production in macrophages triggers the activation of NLRP3 inflammasome (Dostert et al., 2008; Eisenbarth et al., 2008), the levels of the mitochondrial ROS was detected.”
BackgroundAMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites
Kim, L. K., Morita, R., Kobayashi, Y., Eisenbarth, S. C., Lee, C. G., Elias, J. A., Eynon, E. E., & Flavell, R. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507393112 · Cited by 69
“These results are in contrast to previous reports showing less inflammation in Casp1 mice after OVA administration (22) and increased levels of IL-1β in asthma patients (23–25).”
MethodResultSelf-citationMast Cells in Allergic Asthma and Beyond
Reuter, S., Stassen, M., & Taube, C. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.6.797 · Cited by 74
Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile
Garçon, N., Wettendorff, M. A., & Mechelen, M. V. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.573624 · Cited by 62
“Here, various innate mechanisms can be activated, including the stimulation of pathogen recognition receptors (PRRs) [4-6].”
BackgroundInfluentialAlum: an old dog with new tricks
Wen, Y., & Shi, Y. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.40 · Cited by 63
Manna, S., Howitz, W. J., Oldenhuis, N. J., Eldredge, A. C., Shen, J., Naorem, N., Lodoen, M. B., Guan, Z., & Esser-Kahn, A. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00218 · Cited by 62
Denton, A. E., Dooley, J., Cinti, I., Silva-Cayetano, A., Fra-Bidó, S., Innocentin, S., Hill, D. L., Carr, E. J., McKenzie, A. N. J., Liston, A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abk0018 · Cited by 66
“The exact mode of action of Alum remains controversial (47), with the NALP3 inflammasome being the most strongly indicated mechanistic pathway (48).”
BackgroundHyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
Si, K., Wei, C., Xu, L., Zhou, Y., Lv, W., Dong, B., Wang, Z., Huang, Y., Wang, Y., & Chen, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770815 · Cited by 63
“knockdown of NAPDH subunit expressions can inhibit MSUinduced inflammasome activation (30, 31).”
BackgroundJaeger, V. K., Hoffman, H. M., van der Poll, T., Tilson, H. H., Seibert, J., Speziale, A., Junge, G., Franke, K., Vritzali, E., Hawkins, P. N., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex185 · Cited by 58
Leuthard, D., Duda, A., Freiberger, S. N., Weiss, S., Dommann, I., Fenini, G., Contassot, E., Kramer, M. F., Skinner, M. A., Kündig, T. M., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800035 · Cited by 60
Liang, Z., Yang, Y., Yu, G., Zhu, H., Xia, X., Chen, C., Fu, D., Li, M., Cheng, G., Xue, C., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120960 · Cited by 58
Miura, N., Shaheen, S. M., Akita, H., Nakamura, T., & Harashima, H. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv008 · Cited by 60
“Among cytokines induced by KALA-MEND, IL-6, IFN- and IL-1 are key modulators for DCs for the effective induction of adaptive immunity (57,58).”
BackgroundThe NLRP3 Inflammasome and Its Role in T1DM
Sun, X., Pang, H., Li, J., Luo, S., Huang, G., Li, X., Xie, Z., & Zhou, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01595 · Cited by 60
“Caspase-1, also called IL-1β-converting enzyme, is an effector protein of the inflammasome that cleaves inactive proinflammatory cytokines, including pro-IL1β and pro-IL-18, to produce activated IL-1β and IL-18 (Figure 1) (23, 24).”
BackgroundUnderstanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy
Tan, J., Ding, B., Teng, B., Ma, P., & Lin, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202111670 · Cited by 60
Nod1, Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis?
Bogefors, J., Rydberg, C., Uddman, R., Fransson, M., Månsson, A., Benson, M., Adner, M., & Cardell, L. O. (2010) · Allergy · doi:10.1111/j.1398-9995.2009.02315.x · Cited by 56
Cellular localization of NLRP3 inflammasome
Wang, Y., Yang, C., Mao, K., Chen, S., Meng, G., & Sun, B. (2013) · Protein & Cell · doi:10.1007/s13238-013-2113-2 · Cited by 59
“DISCUSSION The NLRP3 inflammasome is critical for protection against pathogens and induction of adaptive immune responses (Eisenbarth et al., 2008; Ichinohe et al., 2009).”
BackgroundChisholm, C. F., Nguyen, B. H., Soucie, K. R., Torres, R. M., Carpenter, J. F., & Randolph, T. W. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24573 · Cited by 55
Huang, Y., Jin, N., Roark, C. L., Aydintug, M. K., Wands, J. M., Huang, H., O'Brien, R. L., & Born, W. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804104 · Cited by 55
“Aluminum adjuvants (alum), currently the most widely used adjuvants in human and animal vaccines, stimulate the innate system and can favor Th2-biased reactivity (4).”
BackgroundP2X7R: A potential key regulator of acute gouty arthritis
Tao, J., Zhang, Y., & Li, X.-P. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.04.007 · Cited by 59
Sarvestani, S. T., & McAuley, J. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.10.020 · Cited by 60
Ichinohe, T. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.118 · Cited by 61
A Role for the Inflammasome in Spontaneous Labor at Term with Acute Histologic Chorioamnionitis
Gomez‐Lopez, N., Romero, R. J., Xu, Y., Plazyo, O., Unkel, R., Than, N. G., Chaemsaithong, P., Chaiworapongsa, T., Dong, Z., Tarca, A. L., et al. (2017) · Reproductive Sciences · doi:10.1177/1933719116675058 · Cited by 57
A Guide to IL ‐1 family cytokines in adjuvanticity
Muñoz‐Wolf, N., & Lavelle, E. C. (2018) · FEBS Journal · doi:10.1111/febs.14467 · Cited by 62
Addressing Nanomaterial Immunosafety by Evaluating Innate Immunity across Living Species
Boraschi, D., Alijagić, A., Auguste, M., Barbero, F., Ferrari, E., Hernádi, S., Mayall, C., Michelini, S., Pacheco, N. I. N., Prinelli, A., et al. (2020) · Small · doi:10.1002/smll.202000598 · Cited by 63
Enhancing the Magnitude of Antibody Responses through Biomaterial Stereochemistry
Appavu, R., Chesson, C. B., Koyfman, A. Y., Snook, J. D., Kohlhapp, F. J., Zloza, A., & Rudra, J. S. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00139 · Cited by 55
Liu, F., Sun, J., Yu, W., Jiang, Q., Pan, M., Xu, Z., Mo, F., & Liu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119928 · Cited by 53
Jain, S., Batra, H., Yadav, P., & Chand, S. (2020) · Vaccines · doi:10.3390/vaccines8040649 · Cited by 61
“A well-known adjuvant, alum, for instance, is known to activate Nalp3 inflammasome and activate Th2 T-cell response [34,35].”
BackgroundResearch Progress of Aluminum Phosphate Adjuvants and Their Action Mechanisms
Zhang, T., Peng, H., Guo, D., Chen, K., Hu, Z., & Zou, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061756 · Cited by 59
“Caspase-1 then promotes the activation of IL-1β and IL-18 [52,53], which in turn promote the differentiation of CD4+ T cells into Th2 cells, enhancing the immune response, and Th2 cells stimulate the production of antibodies by B cells through secretion of cytokines to form humoral immunity [45,54].”
BackgroundMakidon, P. E., Belyakov, I. M., Blanco, L. P., Janczak, K. W., Landers, J. J., Bielinska, A. U., Groom, J. V., & Baker, J. R. (2012) · European Journal of Immunology · doi:10.1002/eji.201142346 · Cited by 58
Activation of adjuvant core response genes by the novel adjuvant PCEP
Awate, S., Wilson, H. L., Lai, K., Babiuk, L. A., & Mutwiri, G. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.03.026 · Cited by 53
TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants
Higgins, S. C., & Mills, K. H. G. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-009-0080-9 · Cited by 62
Bryant, C. E., Orr, S. J., Ferguson, B. J., Symmons, M. F., Boyle, J. P., & Monie, T. P. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009928 · Cited by 57
“Phagocytosis of particulate and crystalline material can result in activation of the NLRP3 inflammasome after rupture of lysosomes and the release of their contents into the cytoplasm (Cassel et al., 2008; Eisenbarth et al., 2008; Halle et al., 2008; Hornung et al., 2008; Dostert et al., 2009; Duewell et al., 2010).”
BackgroundMethodInfluentialInflammasome Activation in Chronic Glomerular Diseases
Conley, S. M., Abais, J. M., Boini, K. M., & Li, P. (2016) · Current Drug Targets · doi:10.2174/1389450117666160817103435 · Cited by 54
“Uptake of particulate and crystalline matter is reported to cause disruption of the lysosomal compartment causing cathepsin B release that may lead to NLRP3 inflammasome activation [28, 37, 41].”
BackgroundNLRP inflammasome as a key role player in the pathogenesis of environmental toxicants
Moloudizargari, M., Moradkhani, F., Asghari, N., Fallah, M., Asghari, M. H., Moghadamnia, A. A., & Abdollahi, M. R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116585 · Cited by 56
Johnson, L., Duschl, A., & Himly, M. (2020) · Vaccines · doi:10.3390/vaccines8020237 · Cited by 60
“Preliminary in vivo studies reported that mice deficient in the NLRP3 gene showed a reduced antibody response [39].”
BackgroundEgan, P. M., Belfast, M., Giménez, J. A., Sitrin, R. D., & Mancinelli, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.054 · Cited by 53
Mortality risks from a spectrum of causes associated with sand and dust storms in China
Zhang, C., Yan, M., Du, H., Ban, J., Chen, C., Liu, Y., & Li, T. (2023) · Nature Communications · doi:10.1038/s41467-023-42530-w · Cited by 66
Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7
Jin, X., Liu, D., Zhou, X., Luo, X., Huang, Q., & Huang, Y. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101310 · Cited by 61
“In addition to MSU, nigericin, and ATP, we also examined the inhibitory effect of ENB on inflammasome activation induced by other NLRP3 stimuli, including imiquimod, 35 alum, 36,37 and SiO 2 .”
BackgroundKvarnhammar, A. M., Petterson, T., & Cardell, L. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03492.x · Cited by 59
Mishra, P. K., Wu, W., Rozo, C. T., Hallab, N. J., Benevenia, J., & Gause, W. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101392 · Cited by 55
“Alternatively, Alum has also been shown to trigger a strong innate immune response resulting in activation of the nod-like receptor protein 3 (NLRP3) inflammasome, resulting in caspase1-mediated conversion of members of the IL-1 family to active cytokines (34, 35).”
BackgroundUnequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line
Mold, M., Eriksson, H., Siesjö, P., Darabi, A., Shardlow, E., & Exley, C. (2014) · Scientific Reports · doi:10.1038/srep06287 · Cited by 52
Juul‐Madsen, H. R., Viertlboeck, B. C., Härtle, S., Smith, A. L., & Göbel, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396965-1.00007-8 · Cited by 72
Halliday, A., Turner, J. D., Guimaraes, A. F., Bates, P. A., & Taylor, M. J. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1381-0 · Cited by 59
“Mechanisms which have been attributed to Alum’s ability to potentiate immune responses include activation of the NOD-like receptor family, pyrin-domaincontaining 3 (NLRP3) inflammasome [45], and induction of cell death followed by subsequent release of endogenous danger signals [46].”
BackgroundNLR‐containing inflammasomes: Central mediators of host defense and inflammation
Fitzgerald, K. A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040331 · Cited by 52
Kuraoka, M., Liao, D., Yang, K., Allgood, S. D., Levesque, M. C., Kelsoe, G. H., & Ueda, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901548 · Cited by 54
“Whereas immunization did increase serum IgM in CD154 / mice, these increases were nonspecific and likely represent a general immune activation driven by the inflammatory properties of alum (89).”
BackgroundMitochondrial function is required for extracellular ATP-induced NLRP3 inflammasome activation
Sadatomi, D., Nakashioya, K., Mamiya, S., Honda, S., Kameyama, Y., Yamamura, Y., Tanimura, S., & Takeda, K. (2017) · The Journal of Biochemistry · doi:10.1093/jb/mvw098 · Cited by 58
“We further examined the effect of CCCP on IL-1b release induced by particulate substances, such as MSU and aluminum hydroxide (Alum) (21, 22).”
BackgroundKaur, B. P., & Secord, E. A. (2021) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.07.003 · Cited by 73
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.